This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Semaglutide, the popular drug sold by Novo Nordisk as ...

On Thursday, Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) announced results from the Phase 3 PATINA trial. The trial demonstrated that the addition of IBRANCE (palbociclib) to ...

FILE PHOTO: The Pfizer logo is seen at their world headquarters in Manhattan, New York, U.S. (Reuters) - Pfizer Inc said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage ...

The breast cancer medication Ibrance has been the shooting star in Pfizer’s universe, and it’s expected to burn brightly enough to raise the entire company’s fortunes. That’s despite Ibrance’s ...

Matthew Herper covers medical innovation — both its promise and its perils. Pfizer said Thursday its drug Ibrance showed efficacy in a group of breast cancer patients who do not currently have access ...

First Cyclin-Dependent Kinase 4/6 (CDK 4/6) Inhibitor Approved by the FDA IBRANCE Now Available for Use in Combination with Letrozole as First-Line Treatment of Postmenopausal Women with Estrogen ...

Approval of expanded indication based predominately on real-world data NEW YORK--(BUSINESS WIRE)-- Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a ...

Pfizer breast-cancer fighter Ibrance posted a rare sales miss Tuesday, but it wasn't because new rivals are stealing its share. The fast-growing blockbuster still boasts a 91% share of the CDK 4/6 ...

Those were the findings of the phase 3 PALOMA-3 trial, presented May 30 during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology ...

DUBLIN--(BUSINESS WIRE)--The "Ibrance - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering. "Ibrance Drug Insight, 2019" highlights the drug marketed details and the Global ...

Expect to pay more for some prescription drugs in 2020 as pharmaceutical companies such as Pfizer, GlaxoSmithKline PLC and Sanofi SA will institute a price hike on over 200 drugs beginning Wednesday, ...

Oct 9 (Reuters) - Pfizer Inc (PFE.N), opens new tab said on Friday its cancer drug Ibrance did not meet the main goal in a late-stage trial in patients with a type of breast cancer, the latest setback ...